Larribère L - Search Results

1

MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma.

Orouji E, Orouji A, Gaiser T, Larribère L, Gebhardt C, Utikal J. Orouji E, et al. Among authors: larribere l. Int J Cancer. 2016 May 1;138(9):2257-62. doi: 10.1002/ijc.29970. Epub 2016 Jan 11. Int J Cancer. 2016. PMID: 26684394

2

SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Hüser L, Sachindra S, Granados K, Federico A, Larribère L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: larribere l. Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. Int J Cancer. 2018. PMID: 29905375

3

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.

Orouji E, Federico A, Larribère L, Novak D, Lipka DB, Assenov Y, Sachindra S, Hüser L, Granados K, Gebhardt C, Plass C, Umansky V, Utikal J. Orouji E, et al. Among authors: larribere l. Int J Cancer. 2019 Dec 15;145(12):3462-3477. doi: 10.1002/ijc.32432. Epub 2019 Jun 9. Int J Cancer. 2019. PMID: 31131878

4

Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter.

Bernhardt M, Orouji E, Larribere L, Gebhardt C, Utikal J. Bernhardt M, et al. Among authors: larribere l. Clin Cancer Res. 2014 May 1;20(9):2498-9. doi: 10.1158/1078-0432.CCR-13-2349. Clin Cancer Res. 2014. PMID: 24789037 No abstract available.

5

TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.

Weina K, Wu H, Knappe N, Orouji E, Novak D, Bernhardt M, Hüser L, Larribère L, Umansky V, Gebhardt C, Utikal J. Weina K, et al. Among authors: larribere l. Pigment Cell Melanoma Res. 2016 Jul;29(4):453-8. doi: 10.1111/pcmr.12483. Pigment Cell Melanoma Res. 2016. PMID: 27105574

6

Multiple roles of NF1 in the melanocyte lineage.

Larribère L, Utikal J. Larribère L, et al. Pigment Cell Melanoma Res. 2016 Jul;29(4):417-25. doi: 10.1111/pcmr.12488. Pigment Cell Melanoma Res. 2016. PMID: 27155159 Review.

7

Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response.

Bernhardt M, Novak D, Assenov Y, Orouji E, Knappe N, Weina K, Reith M, Larribere L, Gebhardt C, Plass C, Umansky V, Utikal J. Bernhardt M, et al. Among authors: larribere l. Stem Cell Reports. 2017 May 9;8(5):1379-1391. doi: 10.1016/j.stemcr.2017.03.007. Epub 2017 Apr 6. Stem Cell Reports. 2017. PMID: 28392221 Free PMC article.

8

New role of ID3 in melanoma adaptive drug-resistance.

Sachindra, Larribère L, Novak D, Wu H, Hüser L, Granados K, Orouji E, Utikal J. Sachindra, et al. Among authors: larribere l. Oncotarget. 2017 Nov 27;8(66):110166-110175. doi: 10.18632/oncotarget.22698. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299138 Free PMC article.

9

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy.

Reinhard R, Gebhardt C, Maurier N, Larribère L, Orouji A, Utikal J. Reinhard R, et al. Among authors: larribere l. JAAD Case Rep. 2018 Jan 16;4(2):129-131. doi: 10.1016/j.jdcr.2017.09.007. eCollection 2018 Mar. JAAD Case Rep. 2018. PMID: 29387762 Free PMC article. No abstract available.

10

Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.

Wu H, Larribère L, Sun Q, Novak D, Sachindra S, Granados K, Umansky V, Utikal J. Wu H, et al. Among authors: larribere l. Int J Cancer. 2018 Dec 1;143(11):2962-2972. doi: 10.1002/ijc.31799. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 30110134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters